MICHAEL ITTMANN to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.128
-
Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors. Oncotarget. 2017 Jan 24; 8(4):6179-6192.
Score: 0.124
-
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. Clin Cancer Res. 2008 Nov 15; 14(22):7511-8.
Score: 0.004